Yuh-Min Chen

6.6k citations
107 papers · 3.3k indexed · 1 hit paper · h-index 31

Impact in

  • Oncology top 1%
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies
    • HER2/EGFR in Cancer Research
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment

Papers in

    • Lung Cancer Research Studies 28
    • Colorectal Cancer Treatments and Studies 9
    • Cancer Immunotherapy and Biomarkers 7
    • Lung Cancer Treatments and Mutations 50
    • Lung Cancer Diagnosis and Treatment 26
    • Gastric Cancer Management and Outcomes 5

Yuh-Min Chen

106 papers receiving 3.3k citations

Hit Papers

Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial 2012 · 776 citations
7762012202620162021250500750

Peers

Yuh-Min Chen
Comparison fields: 5 of 160
  • Oncology 1.7k
  • Pulmonary and Respiratory Medicine 1.9k
  • Cancer Research 426
  • Endocrine and Autonomic Systems 89
  • Molecular Biology 809
Replace Yuh‐Min Chen with:
Yuh‐Min Chen Taiwan
Piet Bakker Netherlands
Per Sandström Sweden
James P. Evans United States
Antonella Petrillo Italy
Peter Bell United Kingdom
Richard I. Levin United States
David Bell Canada
Pierre Blanchard France
Jean‐Noël Talbot France
Yuh-Min Chen relative to Yuh‐Min Chen Taiwan Yuh‐Min Chen's profile →
Citations per field
00.5×1.5×
Yuh‐Min Chen · 1×
Citations per year

Countries citing papers authored by Yuh-Min Chen

Since Specialization
Citations

This map shows the geographic impact of Yuh-Min Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuh-Min Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuh-Min Chen more than expected).

Fields of papers citing papers by Yuh-Min Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuh-Min Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuh-Min Chen. The network helps show where Yuh-Min Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Yuh-Min Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yuh-Min Chen Line = papers co-authored together Yuh-Min Chen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20246
3 20241
4 20213
5 2021100
6 20218
7 202055
8 202058
9 201637
10 20169
11 20159
12 201444
13 201410
14 201126
15 201121
16 201151
17 201026
18 200512
19 200143
20 19953

About Yuh-Min Chen

Yuh-Min Chen is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Industrial and Manufacturing Engineering, Management of Technology and Innovation and Infectious Diseases, having authored 107 papers that have together received 3.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (50 papers), Lung Cancer Research Studies (28 papers), Lung Cancer Diagnosis and Treatment (26 papers), Colorectal Cancer Treatments and Studies (9 papers), Manufacturing Process and Optimization (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Digital Marketing and Social Media (5 papers) and Gastric Cancer Management and Outcomes (5 papers). The work is most often cited by research in Oncology (1.7k citations), Pulmonary and Respiratory Medicine (1.9k citations), Cancer Research (426 citations), Endocrine and Autonomic Systems (89 citations) and Molecular Biology (809 citations). Yuh-Min Chen has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Reury-Perng Perng, Jacqueline Whang‐Peng, Chun-Ming Tsai, James Chih‐Hsin Yang, Wu‐Chou Su, Sang-We Kim, Mengzhao Wang, Vera Hirsh, Robert M. Lorence and Kun‐Ta Chou. Their work appears in journals such as Lung Cancer, Journal of Thoracic Oncology, CHEST Journal, Journal of Immunotherapy and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026